visión de conjunto:Críticas 4-Star Review! This is an unparalleled resource in both content and authority for pediatric infectious diseases knowledge from diagnosis to management and prevention. Kari A. Simonsen MD University of Nebraska Medical Center Doody's Book Review Reseña del editor Each successive edition of this incomparable one-stop guide to preventing controlling and managing infectious diseases in children has set new standards of quality authority and value. Few books of its size contain material that has as wide a readership and as faithful a following. Like its distinguished predecessors the 30th edition is custom-built for efficient patient problem solving. At its heart are expert recommendations on the clinical manifestations etiology epidemiology diagnosis and treatment of more than 200 different diseases. Created by the AAP Committee on Infectious Diseases and reviewed by the CDC and FDA-with contributions from hundreds of expert physicians-it is the clinical tool you will consult often and with complete confidence. The new edition has been thoroughly revised and updated to help you stay in step with the latest developments and recommendations. Red Book 2015 Product Highlights: All chapters and sections have been updated Key developments in combination vaccines 2015 AAP standards for child and adolescent immunization practices Important findings on drug interactions Content includes: Summary of Major Changes in the Red Book Section 1: Active and Passive Immunization Section 2: Recommendations for Care of Children in Special Circumstances Section 3: Summaries of Infectious Diseases Section 4: Antimicrobial Agents and Related Therapy Section 5: Antimicrobial Prophylaxis Biografía del autor Editor: David W. Kimberlin MD FAAP is the Principal Investigator for the Collaborative Antiviral Study Group (CASG) a network of pediatric academic medical centers that evaluates antiviral therapeutics in rare diseases with a large unmet medical need including neonatal herpes simplex virus (HSV) infections congenital cytomegalovirus (CMV) disease neonatal and infantile influenza infection neonatal enteroviral sepsis syndrome and juvenile-onset recurrent respiratory papillomatosis. Studies conducted by the CASG have led to new drug indications and label changes for acyclovir valganciclovir and oseltamivir and non-CASG studies conducted by Dr. Kimberlin also have led to label changes for valacyclovir. Dr. Kimberlin is Editor of the 2015 AAP Report of the Committee on Infectious Diseases (Red Book) and will be the editor for the 2018 edition as well. He is Past-President of the Pediatric Infectious Diseases Society (PIDS) which is the world's largest organization of professionals dedicated to the treatment control and eradication of infectious diseases affecting children. Dr. Kimberlin also serves as Vice Chair for Clinical and Translational Research in the UAB Department of Pediatrics where he holds the Sergio Stagno Endowed Chair in Pediatric Infectious Diseases and is Co-Director of the Division of Pediatric Infectious Diseases. Associate editors: Michael T. Brady MD FAAP is Professor of Pediatrics at The Ohio State University and Associate Medical Director at Nationwide Children's Hospital. Dr. Brady was on the AAP Committee on Infectious Diseases from 2005 until 2014 (Chair from 2010 to 2014). Dr. Brady was an Associate Editor of the 2015 Red Book. Dr. Brady received his medical degree from Jefferson Medical College in Philadelphia. His pediatric residency was completed at Nationwide children's Hospital in Columbus Ohio and Baylor College of Medicine in Houston. His pediatric infectious diseases fellowship was at the Baylor College of Medicine. Dr. Brady's special interests include HIV infection healthcare-associated infections perinatal infections and vaccine-preventable infections. He is currently a member of the Board of Scientific Counselors - Infectious Diseases at the Centers for Disease Control and Prevention. Mary Anne Jackson MD FAAP Following residency at Cincinnati Children's and fellowship at the University of Texas Southwestern Dr. Jackson has been a faculty member at Children's Mercy Hospital Kansas City since 1984 where she is Division Director of Infectious Diseases. She has won numerous teaching awards and was honored in 2012 as the outstanding graduate at the University of Missouri-Kansas City School of Medicine. A fellow of the AAP the Infectious Disease Society of America and the Pediatric Infectious Disease Society she has also been elected to the American Pediatric Society the Society of Pediatric Research and the Academic Pediatric Association. She has been a member of the AAP Committee on Infectious Diseases since 2009 and is an Associate Editor of Red Book(TM) 2015. She has authored over 150 peer reviewed publications focusing on strategies to reduce the incidence of hospital acquired infection judicious use of antibiotics prevention of antibiotic resistant infection and vaccine implementation and education. Sarah S. Long MD FAAP is Section Chief of Infectious Diseases at St. Christopher's Hospital for Children in Philadelphia PA. Dr. Long is also Professor of Pediatrics at Drexel University College of Medicine. Dr. Long is an associate editor of The Journal of Pediatrics and is the chief editor of the textbook Principles and Practice of Pediatric Infectious Diseases. She has received numerous teaching awards the Distinguished Service Award of the Pediatric Infectious Diseases Society the Clinical Teacher Award of the Infectious Diseases Society of America and the Award for Lifetime Contribution to Infectious Diseases Education by the Section on Infectious Diseases of the American Academy of Pediatrics. Dr. Long completed her medical degree at Jefferson Medical College in Philadelphia and her residency and fellowship at St. Christopher's Hospital for Children. She is board certified in pediatrics and pediatric infectious disease and her principal areas of research are vaccine-preventable diseases and management of common infectious diseases in children. She sits on advisory committees for the National Institutes of Health the Food and Drug Administration and the Centers for Disease Control and Prevention.